These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

381 related articles for article (PubMed ID: 28223801)

  • 1. Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus - current status.
    Ganesan P; Arulselvan P; Choi DK
    Int J Nanomedicine; 2017; 12():1097-1111. PubMed ID: 28223801
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent trends in the development of nanophytobioactive compounds and delivery systems for their possible role in reducing oxidative stress in Parkinson's disease models.
    Ganesan P; Ko HM; Kim IS; Choi DK
    Int J Nanomedicine; 2015; 10():6757-72. PubMed ID: 26604750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current advancements related to phytobioactive compounds based liposomal delivery for neurodegenerative diseases.
    Khot KB; Gopan G; Bandiwadekar A; Jose J
    Ageing Res Rev; 2023 Jan; 83():101806. PubMed ID: 36427765
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanodelivery of phytobioactive compounds for treating aging-associated disorders.
    Lushchak O; Strilbytska O; Koliada A; Zayachkivska A; Burdyliuk N; Yurkevych I; Storey KB; Vaiserman A
    Geroscience; 2020 Feb; 42(1):117-139. PubMed ID: 31686375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral Nano Drug Delivery Systems for the Treatment of Type 2 Diabetes Mellitus: An Available Administration Strategy for Antidiabetic Phytocompounds.
    Nie X; Chen Z; Pang L; Wang L; Jiang H; Chen Y; Zhang Z; Fu C; Ren B; Zhang J
    Int J Nanomedicine; 2020; 15():10215-10240. PubMed ID: 33364755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bioactive Agent Discovery from the Natural Compounds for the Treatment of Type 2 Diabetes Rat Model.
    Yang SC; Hsu CY; Chou WL; Fang JY; Chuang SY
    Molecules; 2020 Dec; 25(23):. PubMed ID: 33287318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microfluidization trends in the development of nanodelivery systems and applications in chronic disease treatments.
    Ganesan P; Karthivashan G; Park SY; Kim J; Choi DK
    Int J Nanomedicine; 2018; 13():6109-6121. PubMed ID: 30349240
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methods for insulin delivery and glucose monitoring in diabetes: summary of a comparative effectiveness review.
    Golden SH; Sapir T
    J Manag Care Pharm; 2012 Aug; 18(6 Suppl):S1-17. PubMed ID: 22984955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo dual-delivery of glucagon like peptide-1 (GLP-1) and dipeptidyl peptidase-4 (DPP4) inhibitor through composites prepared by microfluidics for diabetes therapy.
    Araújo F; Shrestha N; Gomes MJ; Herranz-Blanco B; Liu D; Hirvonen JJ; Granja PL; Santos HA; Sarmento B
    Nanoscale; 2016 May; 8(20):10706-13. PubMed ID: 27150301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Advances in the treatment of type 2 diabetes mellitus.
    Israili ZH
    Am J Ther; 2011; 18(2):117-52. PubMed ID: 19834322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrated serum pharmacochemistry and network pharmacology analyses reveal the bioactive metabolites and potential functional mechanism of ground cherry (Physalis pruinosa L.) in treatment of type 2 diabetes mellitus in rats.
    Mahana A; Hammoda HM; Khalifa AA; Elblehi SS; Harraz FM; Shawky E
    J Ethnopharmacol; 2023 Jan; 300():115750. PubMed ID: 36162547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The methanolic extract of Thymus praecox subsp. skorpilii var. skorpilii restores glucose homeostasis, ameliorates insulin resistance and improves pancreatic β-cell function on streptozotocin/nicotinamide-induced type 2 diabetic rats.
    Cam ME; Hazar-Yavuz AN; Yildiz S; Ertas B; Ayaz Adakul B; Taskin T; Alan S; Kabasakal L
    J Ethnopharmacol; 2019 Mar; 231():29-38. PubMed ID: 30399410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel Gymnema sylvestre extract stimulates insulin secretion from human islets in vivo and in vitro.
    Al-Romaiyan A; Liu B; Asare-Anane H; Maity CR; Chatterjee SK; Koley N; Biswas T; Chatterji AK; Huang GC; Amiel SA; Persaud SJ; Jones PM
    Phytother Res; 2010 Sep; 24(9):1370-6. PubMed ID: 20812281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioactive Compounds Effective Against Type 2 Diabetes Mellitus: A Systematic Review.
    Egbuna C; Awuchi CG; Kushwaha G; Rudrapal M; Patrick-Iwuanyanwu KC; Singh O; Odoh UE; Khan J; Jeevanandam J; Kumarasamy S; Chukwube VO; Narayanan M; Palai S; Găman MA; Uche CZ; Ogaji DS; Ezeofor NJ; Mtewa AG; Patrick-Iwuanyanwu CC; Kesh SS; Shivamallu C; Saravanan K; Tijjani H; Akram M; Ifemeje JC; Olisah MC; Chikwendu CJ
    Curr Top Med Chem; 2021; 21(12):1067-1095. PubMed ID: 33966619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DLBS3233, a combined bioactive fraction of Cinnamomum burmanii and Lagerstroemia speciosa, in type-2 diabetes mellitus patients inadequately controlled by metformin and other oral antidiabetic agents.
    Tjokroprawiro A; Murtiwi S; Tjandrawinata RR
    J Complement Integr Med; 2016 Dec; 13(4):413-420. PubMed ID: 27451997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral antidiabetic agents: current role in type 2 diabetes mellitus.
    Krentz AJ; Bailey CJ
    Drugs; 2005; 65(3):385-411. PubMed ID: 15669880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transition from passive to active targeting of oral insulin nanomedicines: enhancement in bioavailability and glycemic control in diabetes.
    Kaklotar D; Agrawal P; Abdulla A; Singh RP; Mehata AK; Singh S; Mishra B; Pandey BL; Trigunayat A; Muthu MS
    Nanomedicine (Lond); 2016 Jun; 11(11):1465-86. PubMed ID: 27171572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Whole Alga, Algal Extracts, and Compounds as Ingredients of Functional Foods: Composition and Action Mechanism Relationships in the Prevention and Treatment of Type-2 Diabetes Mellitus.
    Bocanegra A; Macho-González A; Garcimartín A; Benedí J; Sánchez-Muniz FJ
    Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New insights toward molecular and nanotechnological approaches to antidiabetic agents for Alzheimer's disease.
    Pradhan SP; Sahu PK; Behera A
    Mol Cell Biochem; 2023 Dec; 478(12):2739-2762. PubMed ID: 36949264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of acute oral toxicity, anti-diabetic and antioxidant effects of Aloe vera flowers extract.
    Elkomy NMIM; El-Shaibany A; Elnagar GM; Abdelkhalek AS; Al-Mahbashi H; Elaasser MM; Raweh SM; Aldiyarbi MA; Raslan AE
    J Ethnopharmacol; 2023 Jun; 309():116310. PubMed ID: 36863642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.